Upcoming and Past Presentations

Upcoming and Past Presentations

Presentations

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

A Tailored Approach to Non-Melanoma Skin Cancers: Managing the High-Risk Patient With Systemic Immune-Activating Therapy

At the 2025 ACMS meeting Drs. Miller and Patel discuss pearls in managing the high-risk patient with systemic immune-activating therapy

David M. Miller, Vishal A. Patel

The Evolving Treatment Landscape of Non-Melanoma Skin Cancer: Implications for Dermatology

At the GW School of Medicine Dermatology Grand Rounds, Dr. Miller provides an overview of the evolving treatment landscape of CSCC and its implications for dermatologists

David M. Miller

Merkel Cell Carcinoma Current Concepts in Diagnosis and Management

At a GW Dermatology resident lecutre in Washington D.C., Dr. Miller provides an overview of the current concepts in diagnosis and management of Merkel Cell Carcinoma

David M. Miller

Merkel Cell Carcinoma Current Concepts in Diagnosis and Management

At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in diagnosis and management of Merkel Cell Carcinoma

David M. Miller

Peri-Operative Management of CSCC

At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in perioperative management of Cutaneous Squamous Cell Carcinoma

David M. Miller

Society of Cutaneous Oncology Journal Club

At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on the recently published CheckMate-358

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Peri-operative Management of High-Risk CSCC

At the 2025, American Academy of Dermatology Annual Meeting ‘What’s New in the Management of Advanced Skin Cancer’ session, Dr. Miller provides pearls on the peri-operative management of high-risk CSCC

David M. Miller

Narrowing Nonmelanoma Skin Cancer Gaps With Neoadjuvant Immunotherapy: Multidisciplinary Strategies for Success

At a AiCME program held at the 2025 American Academy of Dermatology Annual Meeting, Drs. Miller and Patel explore key clinical practice insights for patients with high-risk resectable NMSC

David M. Miller, Vishal Patel

Society of Cutaneous Oncology Journal Club

At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on ctDNA in MCC

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Controversies in Gene Expression Profiling

ODAC Dermatology, Aesthetic & Surgical Conference “General Session”

David M. Miller

Immunotherapy for CSCC - What Dermatologists Should Know

ODAC Dermatology, Aesthetic & Surgical Conference “General Session”

David M. Miller

Collaborative Approaches to Optimize Basal Cell Carcinoma Care Within the Community

Management Pearls for Advanced BCC

David M. Miller

The Evolving Treatment Landscape for CSCC

Reflections on the evolving treatment landscape for CSCC

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Optimizing Melanoma Outcomes in Rural and Underserved Communities: Adapting to Evolving Treatment Paradigms

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous melanoma

David M. Miller

Update in the Management of Advanced Cutaneous Squamous Cell Carcinoma

This live program will explore key clinical practice insights for patients with advanced CSCC

David M. Miller

Update in the Management of Non-Resectable Melanoma

This live program will explore key clinical practice insights for patients with non-resectable melanoma

David M. Miller

Shifting the Approach to Nonmelanoma Skin Cancer in Dermatology

This live program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

David M. Miller

A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies

This program will explore key clinical practice insights for patients with advanced basal cell carcinoma

David M. Miller, Todd Schlessinger

Incorporating Multidisciplinary Care and Immunotherapy to Achieve Optimal Outcomes in Patients With Nonmelanoma Skin Cancers

This HoloVision program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Should Ipilimumab Be the New “Standard” for Refractory MCC?

We discuss the role of Ipilimumab in anti-PD1 refractory MCC

David M. Miller

Updates in Merkel Cell Carcinoma

Pearls on the current concepts in diagnosis and management of MCC

David M. Miller

Peri-operative Management of CSCC

Pearls on peri-omanagement of high-risk resectable CSCC

David M. Miller

The Prognostic Value of the MCPyV Serum Antibody Test

We discuss results from a dual-institution observational study

David M. Miller

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Melanoma Update

ODAC Dermatology, Aesthetic & Surgical Conference “Medical & Surgical Dermatology Topics”

David M. Miller

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

ODAC Dermatology, Aesthetic & Surgical Conference “Non-Melanoma Skin Cancer Update”

David M. Miller

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Interdisciplinary Management of Advanced Cutaneous Malignancy

Management Pearls for the Peri-Operative Management of Melanoma

Putting the Patient First. The Value of Personalized Medicine for Nonmelanoma Skin Cancers

Management Pearls for Advanced NMSC

Management of Cutaneous Melanoma

Management of Cutaneous Melanoma

David M. Miller

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Current concepts in diagnosis and management of MCC

David M. Miller

Nicotinamide For Skin Cancer After Transplant

Discuss the evidende behind the use of nicotinamide for skin cancer prevention

David M. Miller

Prognostic Significance of Initial AMERK Serostatus

We discuss results from a dual-institution observational study

David M. Miller

Immunotherapeutic Strategies in Skin Cancer

Primer on Immunotherapeutic Strategies in Skin Cancer

David M. Miller

StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries

We present an overview of the StoryboardR package

The Emerging Standard of Care - Immunotherapy in Non-Melanoma Skin Cancer

This live program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Mission - Impossible to Possible Using Immunotherapy for the Treatment of Nonmelanoma Skin Cancers

Management Pearls for Advanced CSCC

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer

This live hybrid program will explore key clinical practice insights for patients with advanced and high-risk resectable NMSC

David M. Miller, Sailesh Konda

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

mGODS - Monoclonal Gammopathies Of Dermatological Significance

Pearls for working up monclonal gammopathies in setting of dermatological disease

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Integrating the Latest Evidence on Management of Basal Cell Carcinoma

We discuss implementation of evidence-based strategies for reducing disparities in basal cell carcinoma (BCC) care in rural and underserved settings

David M. Miller

Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous squamous cell carcinoma

David M. Miller

ICARUS

We discuss a trial concept for high-risk CSCC

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma

This live program will explore key clinical practice insights for patients with advanced cutaneous squamous cell carcinoma

David M. Miller, Vishal A. Patel

Updates in Merkel Cell Carcinoma

Pearls on the current concepts in diagnosis and management of MCC

David M. Miller

Management of High Risk Uncommon Cutaneous Neoplasms

Pearls on the current concepts in diagnosis and management of uncommon cutaneous neoplasms

David M. Miller

Management of Operable Advanced NMSC

Pearls on the current concepts in diagnosis and management of operable non-melanoma skin cancer

David M. Miller

How do we implement systemic therapy to reduce recurrence of high-risk melanomas: from neoadjuvant to adjuvant therapy?

Pearls on the current concepts in peri-operative management of high-risk melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Med Learning Group TeleECHO. Event URL

David M. Miller

New Systemic Therapies for the Treatment of Advanced Non-Melanoma Skin Cancers: Which of Your Patients May Benefit?

We review new systemic therapies for the Treatment of Advanced NMSCs

David M. Miller, Vishal A. Patel

The Essential Roles of Dermatologists in Managing Patients with Advanced Basal Cell Carcinoma

This gamification-based activity highlights how to diagnose, treat, and/or manage patients with advanced basal cell carcinoma.

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Med Learning Group TeleECHO. Event URL

David M. Miller

Cutaneous Malignancies: How Would You Manage This Patient?

Interactive session with a series of skin cancer experts discussing management of complex skin cancer patients.

David M. Miller, Douglas Grossman, Steven Wang, Vishal A. Patel

Prognostic Gene Expression Profiling for Cutaneous Squamous Cell Carcinoma: Does it Add to Staging

We discuss the current data regarding prognostic gene expression profiling in CSCC

David M. Miller

Cases in Basal Cell Carcinoma: Fostering Interdisciplinary Care

We discuss cases in the management of advanced BCC.

David M. Miller, Kavita Sarin, Vishal A. Patel

Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices

Med Learning Group TeleECHO. Event URL

David M. Miller

Practical Management Pearls for Immunotherapy for the Treatment of Nonmelanoma Skin Cancer

We discuss perals from the recent SITC practice guidelines on NMSC

Isaac Brownell, David M. Miller, Sunandana Chandra, Emily S. Ruiz

Immunotherapeutic Strategies in Skin Cancer

Primer on Immunotherapeutic Strategies in Skin Cancer

David M. Miller

The Clinician Investigator - A Buttress Against Type III Error or a Contributor to the Crisis in Reproducibility?

In this two part series, we discuss elements of the crisis in reproducibility in clinical research.

David M. Miller

Dealing with Non-Responders to Systemic Therapy for Basal Cell Carcinoma

In this podcase, we discuss pearls on the management of advanced BCC

David M. Miller

mGODS - Monoclonal Gammopathies Of Dermatological Significance

Pearls for working up monclonal gammopathies in setting of dermatological disease

David M. Miller

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

Pearls in the management of Merkel Cell Carcinoma

David M. Miller

Basal Cell Carcinoma: How to Effectively Manage Your Patients

Pearls in the management of Basal Cell Carcinoma

David M. Miller

Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma

Real world evaluation of initial brain MRI in MCC

David M. Miller

Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Sophia-Shalhout

Seeing Nonmelanoma Skin Cancers Through a New Lens - The Role and Place of Immunotherapy

Pearls on the current concepts in diagnosis and management of NMSC

Axel Hauschild, David M. Miller, Vishal Patel

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Pearls on the current concepts in diagnosis and management of MCC

David M. Miller

Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma

Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC

Sophia-Shalhout

Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma

Management Pearls for Advanced CSCC

Kevin Emerick, David M. Miller

Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma

Management Pearls for Advanced CSCC

Kevin Emerick, David M. Miller

Management of Advanced Cutaneous Melanoma

Pearls for the work up and management of cutaneous melanoma

David M. Miller

Non Melanoma Skin Cancer Immunotherapies and the Role of Dermatology Clinicians

Management Pearls for Advanced NMSC

Vishal Patel, Krista Rubin, David M. Miller

Immunotherapy in Advanced NMSC - Treatment Selection and Collaborative Care

Pearls for the Management of Advanced NMSC

Vishal Patel, Krista Rubin, David M. Miller

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

David M. Miller

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

David M. Miller

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

This live virtual Grand Rounds program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas

David M. Miller

Clinical and Translational Research in Cutaneous Oncology

Pearls for a career in CT research in skin cancer

David M. Miller

Management of Cutaneous Melanoma

In this lecture to the Harvard Dermatology residents, we provide pearls for the management of cutaneous melanoma

David M. Miller

Accelerate Health

At the 2021 CEO Roundtable on Cancer Annual Conference we provide an update on the PDS MCC patient registry

David M. Miller, Kerry Reynolds, Bill Louv

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

David M. Miller

The MCC Patient Registry - From Promise to Prototype to Patient

For this MGH Dermatology Grand Rounds we present an overview of the PDS MCC patient registry

David M. Miller

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

David M. Miller

Squamous Cell Carcinoma - Current Concepts in Management

In this lecture for the Nurse Practioners on the Medical Oncology Inpatient Service, we reivew pearls on the current concepts in management of SCC

David M. Miller

GENETEX - A GENomics Report TEXt Mining R Package to Capture Real-World Clinico-genomic Data

We present an overview of the GENETEX package

David M. Miller, Sophia-Shalhout

Nonmelanoma Skin Cancers - Who Is in the Waiting Room

Pearls on the current concepts in diagnosis and management of NMSC

David M. Miller, Hari Nadiminti, Vishal Patel

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

In this talk for the Summer AAD we review pearls on the current concepts in diagnosis and management of MCC.

David M. Miller

Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma

We discuss the utility of brain MRI for the initial staging of MCC

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Pearls on the current concepts in diagnosis and management of MCC

David M. Miller

eLAB - a Large-Scale Laboratory Integration Informatics Pipeline for Clinical Research

Sophia-Shalhout

GENETEX - an NLP R Package for Text Mining Genomic Reports

David M. Miller

Immune Checkpoint Inhibitor for Cutaneous Squamous Cell Carcinoma

Pearls for the Management of Advanced CSCC

Kevin Emerick, Gina Jefferson, Miriam Lango, Matthew Witek, David M. Miller

An Innovative View of Advanced and Metastatic Basal Cell Carcinoma- Pathology, Epidemiology, and Treatment Option

Pearls for the Management of Advanced BCC

David M. Miller, Emily Ruiz

mGODS - Monoclonal Gammopathies Of Dermatological Significance

Pearls for working up monclonal gammopathies in setting of dermatological disease

David M. Miller

MCC Patient Registry - Lessons Learned, Future Directions

David M. Miller

MCC Patient Registry - Lessons Learned on Data Capture

David M. Miller

Work Up and Management of Cutaneous Melanoma

In this online lecture for the DC Resident Consortium, we provide pearls for the work up and management of cutaneous melanoma

David M. Miller

Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient

We provide updates and future directions of the PDS-GOBDA MCC Registry

David M. Miller

Developing Immunotherapy for Advanced Disease - Leveraging the Tumorigenesis of Basal Cell Skin Cancer – A Whiteboard View

Pearls for the Management of Advanced BCC

David M. Miller, Emily Ruiz

Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient

We provide updates and future directions of the PDS MCC Registry

David M. Miller

Squamous Cell Carcinoma - Work Up and Management

Pearls for the Work Up & Management of CSCC

David M. Miller

The Evolving Landscape of Regulatory Medicine in Cutaneous Oncology

Analysis of the changing regulatory environment in skin cancer

David M. Miller

Management of Cutaneous Melanoma

Pearls for the management of cutaneous melanoma

David M. Miller

The MCC Patient Registry - Updates and Future Directions

David Miller
Isaac Brownell
Ting Yu
Hazel Moran
Ravikumar Komandur
Bill Louv
Teilo Schaller
Johnathan Rine

David M. Miller

Salt, Water, Urine, EAV

Pearls for the Evaluation of Hyponatremia

Practical pearls to help evaluate hyponatremia

David M. Miller

Acid-Base Pearls Part 1

The Strong Ion Approach to Acid-Base Disorders

Pearls on how to approach Acid-Base issues commonly seen on inpatient medicine

David M. Miller

Pearls from the Cascade

Overview & Learning Objectives

David M. Miller

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

Overview & Learning Objectives

David M. Miller

Squamous Cell Carcinoma - Epidemiology, Pathophysiology, Work Up and Management

Overview & Learning Objectives

David M. Miller

Heme-Derm - Principles at the Intersection of Blood and Skin

We review overlapping principles of Dermatology and Hematology

David M. Miller

Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management

We review current concepts in diagnosis and management for MCC

David M. Miller

The MCC Patient Registry - From Promise to Prototype to Patient

David M. Miller

MCC Patient Registry - Updates and Future Directions

David M. Miller

Skin Toxicities of Anti-Neoplastic Medications

David M. Miller

Melanoma - Pathogenesis, Clinical Features, Work Up & Management

We review key pearls in melanoma pathogenesis and management

David M. Miller

Therapeutic Updates in Melanoma - IO for Earlier Stage Disease

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement

David M. Miller

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement

David M. Miller

The Evolving Landscape of Regulatory Medicine in Cutaneous Oncology

David M. Miller

Melanoma - Pathogenesis, Clinical Features, Diagnosis and Management

David M. Miller

Targeting the Hippo-YAP Pathway As a novel Therapeutic Approach in Cancer

Sophia-Shalhout

A Case of Bimodality Therapy for Merkel Cell Carcinoma

Clinical Investigation in cSCC - Updates from ASCO and ESMO

David M. Miller

Project Data Sphere and Ongoing Multi-Institutional Database Efforts

We present on the PDS MCC patient registry at the First International Symposium on Merkel Cell Carcinoma

David M. Miller

2019 ASCO IO Abstracts Review

David M. Miller

Work Up and Management of Non-Melanoma Skin Cancer

David M. Miller

Diagnosis and Initial Management of Melanoma

David M. Miller

MCC Patient Registry

Melanoma - Work Up and Management

David M. Miller

Melanoma - Epidemiology and Pathogenesis

David M. Miller

Merkel Cell Carcinoma Tumor Registry

David M. Miller

Approach to the Skin Biopsy

David M. Miller

Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient

Clinical and Translational Research in Cutaneous Oncology

David M. Miller

Cutaneous Oncology Board Preparation

David M. Miller

Regulatory Medicine in Cutaneous Oncology

David M. Miller

Merkel Cell Carcinoma

In this lecture for the GWU School of Medicine Dermatology residents we provide a overview of the diagnosis and managment of Merkel Cell Carcinoma

David M. Miller

Regulatory Medicine in Cutaneous Oncology

David M. Miller

Neoadjuvant PD-1 Blockade in Resectable Melanoma

David M. Miller

Project Data Sphere & the MCC Patient Registry - From Promise to Prototype to Patient

We present the concept of the PDS MCC patient registry at the annual Merkel Cell Carcinoma Interest Group Meeting

David M. Miller

Sezary Syndrome Part 2 - Diagnosis and Management

David M. Miller

Sezary Syndrome Part 1 - Pathogenesis and Clinical Features

David M. Miller

mGODS - Monoclonal Gammopathies Of Dermatological Significance

First described↩︎

David M. Miller

mGODS - Monoclonal Gammopathies of Dermatological Signficance

(https://www.themillerlab.io/talk/harvard_derm_resident_mgods-01-31-17/)↩︎

David M. Miller

Sezary Syndrome

David M. Miller

Reducing M&M in M&M - Strategies to improve Morbidity and Mortality in Melanoma and Merkel cell carcinoma

David M. Miller

FDA Action in Cutaneous Oncology

Overview of regulatory medicine in skin cancer

David M. Miller

Sezary Syndrome

David M. Miller

PDS MCC Tumor Registry

David M. Miller

FDA Action in Cutaneous Oncology

PAMPs, DAMPs and Dermatology

David M. Miller

TCRs, Tsubs and dHSRs - T-cell Immunity for the Dermatologist

David M. Miller

Introduction to Melanoma

David M. Miller

Merkel Cell Carcinoma - Updates in Diagnosis and Management

David M. Miller

Merkel Cell Carcinoma

David M. Miller

Introduction to Melanoma

The Biology of Cutaneous Oncology

David M. Miller

mGODS - Monoclonal Gammopathies of Dermatological Signficance

First described↩︎

David M. Miller

PAMPs DAMPs and Dermatology - Innate Immunity for the Dermatologist

David M. Miller

mGODS - Monoclonal Gammopathies Of Dermatological Significance

First described↩︎

David M. Miller

No Claims No Gains - Why You Need to Know the Business Side of Medicine

David M. Miller, Xin Gao

Common Primary Care Dermatoses

David M. Miller

Sezary Syndrome

David M. Miller

Nivolumab as Adjuvant Therapy for Melanoma

David M. Miller

Common Primary Care Dermatoses

David M. Miller

Common Primary Care Dermatoses

David M. Miller

Introduction to Melanoma

David M. Miller

Sezary Syndrome

David M. Miller

Sezary Syndrome

David M. Miller

Avelumab for Patients with Merkel Cell Carcinoma

David M. Miller

mGODS - Monoclonal Gammopathies Of Dermatological Significance

In this lecture we review the most common dermatoses that result from monoclonal gammopathies. The lecture also introduces the term mGODS: Monoclonal Gammopathies of…

David M. Miller

Scratching the Surface of Acute Graft vs. Host Disease

David M. Miller

Approach to Purpura

David M. Miller

The Red Leg

David M. Miller

Mycosis Fungoides - Clinical Features, Diagnosis & Management

David M. Miller

Merkel Cell Carcinoma

David M. Miller

Cellulitis and Its Mimics

David M. Miller

Vesiculobullous Eruptions

David M. Miller

Common Primary Care Dermatoses

David M. Miller

A Case of Early-Onset Dementia

David M. Miller

A Patient with Fever and Rash

David M. Miller

A Painful Rash

David M. Miller

Melanoma

David M. Miller

Biology of Keratinocytes

David M. Miller

Emerging Therapies in Melanoma

David M. Miller

Environmental and Sports-Related Skin Diseases

David M. Miller

Overstimulated

David M. Miller

Immunology Review - T-Cell Immunity

David M. Miller

Progression After Failure

David M. Miller

Deep Impact

David M. Miller

Melanoma

David M. Miller

Environmental and Sports-Related Skin Diseases

David M. Miller

B-Cell Immunology for the Dermatologist

David M. Miller

T-Cell Immunology for the Dermatologist

David M. Miller

Biology of Keratinocytes

David M. Miller

Severe Scalp SCCs In a Heart Transplant Recipient

David M. Miller

Cutaneous B-Cell Lymphoma

David M. Miller

Melanoma

David M. Miller

Painful Papules

David M. Miller